First Time Loading...
A

Aceso Life Science Group Ltd
HKEX:474

Watchlist Manager
Aceso Life Science Group Ltd
HKEX:474
Watchlist
Price: 0.147 HKD 5% Market Closed
Updated: May 17, 2024

Gross Margin
Aceso Life Science Group Ltd

46.6%
Current
46%
Average
65.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.6%
=
Gross Profit
123m
/
Revenue
264m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
HK
Aceso Life Science Group Ltd
HKEX:474
1.1B HKD
47%
US
American Express Co
NYSE:AXP
174.6B USD
63%
US
Capital One Financial Corp
NYSE:COF
54B USD
0%
IN
Bajaj Finance Ltd
NSE:BAJFINANCE
4.2T INR
62%
US
Discover Financial Services
NYSE:DFS
31.5B USD
0%
US
Synchrony Financial
NYSE:SYF
17.6B USD
0%
IN
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
1.1T INR
51%
US
Santander Consumer USA Holdings Inc
NYSE:SC
12.7B USD
74%
US
Ally Financial Inc
NYSE:ALLY
12.2B USD
0%
BR
Creditaqui Financeira SA - Credito Financiamento e Investimento
BOVESPA:MERC3
56B BRL
0%
IN
Shriram Finance Ltd
NSE:SHRIRAMFIN
891.2B INR
56%
A
Aceso Life Science Group Ltd
HKEX:474
Country HK
Market Cap 1.1B HKD
Gross Margin
47%
American Express Co
NYSE:AXP
Country US
Market Cap 174.6B USD
Gross Margin
63%
Capital One Financial Corp
NYSE:COF
Country US
Market Cap 54B USD
Gross Margin
0%
Bajaj Finance Ltd
NSE:BAJFINANCE
Country IN
Market Cap 4.2T INR
Gross Margin
62%
Discover Financial Services
NYSE:DFS
Country US
Market Cap 31.5B USD
Gross Margin
0%
Synchrony Financial
NYSE:SYF
Country US
Market Cap 17.6B USD
Gross Margin
0%
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
Country IN
Market Cap 1.1T INR
Gross Margin
51%
Santander Consumer USA Holdings Inc
NYSE:SC
Country US
Market Cap 12.7B USD
Gross Margin
74%
Ally Financial Inc
NYSE:ALLY
Country US
Market Cap 12.2B USD
Gross Margin
0%
Creditaqui Financeira SA - Credito Financiamento e Investimento
BOVESPA:MERC3
Country BR
Market Cap 56B BRL
Gross Margin
0%
Shriram Finance Ltd
NSE:SHRIRAMFIN
Country IN
Market Cap 891.2B INR
Gross Margin
56%

Profitability Report

View the profitability report to see the full profitability analysis for Aceso Life Science Group Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.6%
=
Gross Profit
123m
/
Revenue
264m
What is the Gross Margin of Aceso Life Science Group Ltd?

Based on Aceso Life Science Group Ltd's most recent financial statements, the company has Gross Margin of 46.6%.

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.